Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:activeDuring |
human growth hormone
|
| gptkbp:clinicalTrials |
treatment of growth hormone deficiency
|
| gptkbp:date |
FDA_approved
|
| gptkbp:formFactor |
injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
OPKO 1600
|
| gptkbp:manufacturer |
gptkb:OPKO_Health,_Inc.
|
| gptkbp:marketedAs |
gptkb:United_States
|
| gptkbp:sideEffect |
headache
nausea injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
diagnosis of certain medical conditions
|